Adults who have a diagnosis of non-segmental vitiligo may qualify for this clinical research trial and receive investigational medication (recombinant IL-2M) or placebo.

  • Age: ≥ 18 years old
  • Vitiligo for ≥ 6 months
  • BSA ≥ 4% and facial BSA ≥ 0.3%
  • All Fitzpatrick skin types
  • Inadequate response to previous JAKi

Patients will be asked to visit the clinic about 17 times over approximately 54 weeks. There is no cost to participate, and participants will be reimbursed for their time and travel.

For further information on the study, please follow the link:

Study Details | A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007) | ClinicalTrials.gov

Trial ID: NCT06113328

If you are interested in participating in a vitiligo clinical trial, please submit your details and our team will be in touch: expression of interest form


Accreditations & Memberships

Australasian Hair and Wool Research Society
international academy cosmetic dermatology
european medecines agency
deakin university
congress dermatology
bellberry limted
australiasian college dermatologists
australian government national health
australian government ip
australian clinical trials
albinism fellowship australia
american dermatological association
british association of dermatology
international society of dermatology
university of melbourne
Book Appointment